Personalized Medicine to Control Warfarin Therapy
The proposed technology determines a patient’s complete metabolic profile to establish the effective dose of a pharmaceutically active compound tailored specifically for an individual patient. This strategy utilizes a metabolomic approach to develop a real time metabolic profile for a subject with regard to warfarin dosing. The profile may then be correlated with dose response, to provide better dosing efficacy and safety and/or may help identify superior derivative drug candidates. This metabolic phenotyping and its uses are far superior to the use of genotyping which is predictive but does not address the variability that is recognized as a superior diagnostic.
Sector: Medical Technologies
Country: India
Area of Application: Pharmaceutical industry, medical industry
Keywords: Warfarin therapy
Advantages: Improve both the treatment and the effective management of individual anticoagulant therapy strategies. Determines a patient’s complete metabolic profile to establish the effective dose of a pharmaceutically active compound tailored specifically for an individual patient. Metabolic phenotyping and its uses are far superior to the use of genotyping which is predictive but does not address the variability that is recognized as a superior diagnostic. This strategy utilizes a metabolomic approach to develop a real time metabolic profile for a subject with regard to warfarin dosing.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054

Contact Technology Provider